Kimberly-Clark to acquire Tylenol maker Kenvue in $48.7 billion deal

4 1 minute read

Kimberly-Clark to acquire Tylenol maker Kenvue in .7 billion deal — cbsn fusion obgyn discusses tylenol use during pregnancy thumbnail.jpg

Kimberly-Clark, a major player in the consumer health industry, announced on Monday that it will be acquiring Kenvue, the maker of Tylenol, in a cash and stock deal valued at approximately $48.7 billion. This strategic move will bring together two powerhouse companies, combining Kimberly-Clark’s well-known brands like Huggies, Kleenex, and Scott with Kenvue’s portfolio of products including Band-Aid, Benadryl, Listerine, and Neutrogena.

Under the terms of the deal, Kenvue shareholders will receive $3.50 per share in cash and 0.14625 shares of Kimberly-Clark for each Kenvue share they hold at the time of closing. This translates to a total of $21.01 per share based on Kimberly-Clark’s closing price on Friday. Following the acquisition, Kimberly-Clark shareholders are expected to own approximately 54% of the combined company, while Kenvue shareholders will hold around 46%.

CEO of Kimberly-Clark, Mike Hsu, expressed his excitement about the merger, stating that the combined company will be able to serve billions of consumers at every stage of life. Hsu will continue to lead the company as both chairman and chief executive officer.

The deal is set to be finalized in the second half of next year pending approval from shareholders of both companies. This acquisition comes at a time when Kenvue has been in the spotlight due to concerns raised by President Trump about the potential risks associated with Tylenol’s active ingredient, acetaminophen, during pregnancy. Despite these concerns, medical experts and Kenvue maintain that Tylenol is safe for use.

In July, Kenvue announced the departure of CEO Thibaut Mongon as part of a strategic review of the company’s operations. Board member Kirk Perry has stepped in as interim CEO. The headquarters of the combined company will remain in Irving, Texas, with a continued significant presence in Kenvue’s locations.

Overall, the merger between Kimberly-Clark and Kenvue marks a significant development in the consumer health industry. The combined resources and expertise of these two companies are poised to drive innovation and growth in the market, benefiting consumers worldwide.